Clearpoint Neuro Inc (CLPT) News & EventsCLPTNews & EventsClearpoint Neuro Inc

Major Averages Surge Again, Tech Shares Lead Gains

The major averages were sharply higher once again, building on Monday's gains as technology shares continue to lead gains and oil prices continue to drop. Strong quarterly reports from big firms such as Palantir, Caterpillar, and McDonald's helped fuel broad increases, while optimism remains over a U.S.-Iran deal to reopen the Strait of Hormuz potentially on the horizon.Meanwhile, investors are also monitoring reports that the Trump administration is drafting restrictions on certain Chinese-made data center networking components over national security concerns, a move that could have implications for AI infrastructure and semiconductor supply chains.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Palantirprovided areport for Q2Caterpillarreportedand provided its outlook for Q3 and FY26 revenueMcDonald'sreported, while global comparable sales rose 1.3% year-over-yearPfizerreported better-than-expected Q3 earnings and revenue andMerckreportedbut lowered its FY26 earnings outlook2. WALL STREET CALLS:Deutsche BankPalantirto Buy after "exceptional" Q2JPMorganNiketo Underweight on below-consensus estimatesOppenheimerInspire Medicaldespite "noisy" fundamentalsWalmartto Perform at OppenheimerJPMorganPVHto Underweight on estimate risk3. AROUND THE WEB:A Senate report alleges Deutsche Bankand Bank of Americafailed to timely report hundreds of millions of dollars in suspicious transactions linked to Jeffrey Epstein-related accounts, calling for investigations and tougher penalties for compliance failures, Bloomberg reportsApplehas launched a legal complaint at the Investigatory Powers Tribunal over the UK's latest attempt to create a "backdoor" that would allow it to access encrypted customer data, FT saysAnthropic has secured a $10B computing capacity agreement with Nvidia-backed Volta Infra to expand data center access and meet rising demand for its Claude AI products, Bloomberg reportsThe Trump administration has invited staffers from OpenAI, Google, Anthropic, and others to the White House on Tuesday to review the AI oversight framework, The Information saysA review by the New York Times of a dozen lawsuits against Uberby riders that were sexually assaulted or harassed on their rides found the company will scour women's private communications, medical records, and past assaults, using this information to present the women as unreliable narrators of the incidents4. MOVERS:Backblazehigher after, providing guidance for Q3, raising its outlook for FY26, and registering to sell 4.19M shares of stockAmeresco (AMRC) increases after, providing guidance for FY26, and after BNP Paribas upgraded the stock to OutperformPaymentusand Wayfairgain afterClearPoint Neurofalls afterand cutting its guidance for FY26AdaptHealthand Brukerlower after5. EARNINGS/GUIDANCE:Syscoand provided guidance for FY27Shoals Technologies, with EPS and revenue beating consensusBellRing Brandsand raised its outlook for FY26Centurithat CEO Christian Brown said "reflect tremendous year-over-year growth"Graingerand raised its guidance for FY26INDEXES:Near midday, the Dow was up 922.33, or 1.73%, to 54,100.74, the Nasdaq was up 529.64, or 2.04%, to 26,443.54, and the S&P 500 was up 111.50, or 1.47%, to 7,712.00.

Stock Futures Broadly Higher, Oil Prices Slip

Stock futures were broadly higher while crude oil futures were slipping in what appears to be a continuation of Monday's regular trading hour trends. The major indexes began the weeke and month with a wining session as easing tensions in the Middle East sent oil prices sharply lower.Meanwhile, earnings season remains a catalyst, with investors digeseting results from Palantir after Monday's close, followed later this week by reports from AMD, McDonald's, Pfizer, Eli Lilly, Disney and Uber. The market is also preparing for SpaceX's first earnings report since its public listing.Check out this evening's top movers from around Wall Street, compiled by The Fly.HIGHER AFTER EARNINGS -Backblazeup 18.7%Ibottaup 17.9%Jeld-Wenup 16.7%Voyager Technologisup 16.5%Medifastup 15.9%Palantirup 14.1%Inspire Medicalup 12.6%Snapup 7.7%On Semiconductorup 7.3%DOWN AFTER EARNINGS -ClearPointdown 14.6%Powell Industriesdown 13.5%Ichor Holdingsdown 11.5%Better Home & Financedown 10.8%BWX Technologiesdown 4.4%

ClearPoint Neuro Q2 Revenue at $10.88M, Below Consensus

Reports Q2 revenue $10.88M, consensus $12.73M. "Establishing ClearPoint Neuro as the leading neuro cell and gene therapy delivery company has been our number one priority for the last 10 years. Over that time, we have pivoted the company vision, invested more than $200 million, built our unique ecosystem, and earned more than 60 active biopharma partners, many of whom have programs which are now under FDA expedited review," commented Joe Burnett, President and CEO at ClearPoint Neuro. "Exciting news over the past few months from our partners, global regulatory bodies, and our own product development teams have only furthered that conviction."